Brilacidin tetrahydrochloride
CAS No. | 1224095-99-1 | Cat. No. | BCP43398 |
Name | Brilacidin tetrahydrochloride | ||
Synonyms | PMX30063; PMX-30063; PMX 30063; Brilacidin; | ||
Formula | C40H54Cl4F6N14O6 | M. Wt | 1082.7 |
Description | Brilacidin, also known as PMX30063, is an arylamide foldamer designed to replicate the amphiphilic properties of antimicrobial peptides while solving the problems encountered by peptide-based antimicrobials. Brilacidin, a broad-spectrum antibiotic, has potent Gram positive activity and Gram negative coverage, and is highly effective in treating the 'superbug' methicillin-resistant Staphylococcus aureus (MRSA). Brilacidin has low cytotoxicity against mammalian cells selectively targeting bacteria, directly and rapidly disrupting their membranes, resulting in the bacteria's death. Due to this unique mechanism of action (mimicking the host's natural immune response, proven to be successful in fighting off infections over millions of years of evolution), bacterial antibiotic resistance is less likely to develop. | ||
Related Products | 1224095-98-0 (Brilacidin) | ||
Pathways | Microbiology/Virology | ||
Targets | Antibiotic |
Structure

Part data of this page collected from the open network resources, so Biochempartner can not guarantee its accuracy.
For product details of different batches, please contact our Customer
- Service & Tech Support:orders@biochempartner.com
- Website:www.biochempartner.com
Products are for research use only and not for human use. We do not sell to patients.